Ocugen (OCGN) Capital Expenditures (2014 - 2026)
Ocugen (OCGN) posted Capital Expenditures of $6000.0 for Q1 2026, down 96.39% on a QoQ basis from $166000.0 in Q4 2025, and down 62.5% year-over-year from $16000.0 in Q1 2025.
Ocugen (OCGN) Capital Expenditures (2014 - 2026) Analysis & Trends
Ocugen's Capital Expenditures history runs 13 years deep, the most recent figure standing at $6000.0 for Q1 2026.
- Quarterly Capital Expenditures fell 62.5% year-over-year to $6000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $175000.0 (down 83.32% YoY) and the FY2025 annual result came in at $185000.0, down 94.53% from the prior year.
- Capital Expenditures was $6000.0 for Q1 2026 at Ocugen, down from $166000.0 in the prior quarter.
- Across five years, Capital Expenditures topped out at $5.1 million in Q3 2023 and bottomed at -$5.6 million in Q4 2023.
- A 5-year average of $392705.9 and a median of $43000.0 in 2025 frame the typical range for Capital Expenditures.
- Peak annual rise in Capital Expenditures reached 1529.33% in 2023, while the deepest fall reached 1639.06% in 2023.
- Ocugen's Capital Expenditures stood at -$320000.0 in 2022, then tumbled by 1639.06% to -$5.6 million in 2023, then soared by 100.23% to $13000.0 in 2024, then jumped by 1176.92% to $166000.0 in 2025, then sank by 96.39% to $6000.0 in 2026.
- Business Quant data shows OCGN's Capital Expenditures at $6000.0 in Q1 2026, $166000.0 in Q4 2025, and -$40000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -8,939.03 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 43.25 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 133.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 230.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 786,000.00 |
| 10 | Ocugen | 63.79 Mn | 63.79 Mn | - | 6,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6,000.00 |
| Mar 31, 2026 | 6,000.00 |
| Dec 31, 2025 | 166,000.00 |
| Dec 31, 2025 | 166,000.00 |
| Sep 30, 2025 | -40,000.00 |
| Sep 30, 2025 | -40,000.00 |
| Jun 30, 2025 | 43,000.00 |
| Jun 30, 2025 | 43,000.00 |
| Mar 31, 2025 | 16,000.00 |
| Mar 31, 2025 | 16,000.00 |
| Dec 31, 2024 | 13,000.00 |
| Dec 31, 2024 | 13,000.00 |
| Sep 30, 2024 | 3.13 Mn |
| Sep 30, 2024 | 3.13 Mn |
| Jun 30, 2024 | -2.11 Mn |
| Jun 30, 2024 | -2.11 Mn |
| Mar 31, 2024 | 2.35 Mn |
| Mar 31, 2024 | 2.35 Mn |
| Dec 31, 2023 | -5.57 Mn |
| Dec 31, 2023 | -5.57 Mn |